1 – 81 of 81
- show: 100
- |
- sort: year (new to old)
- |
- Export
- 2024
- PI-RADS 5 in prostate magnetic resonance imaging : how important is intraprostatic invasive behavior? (2024) European Congress of Radiology 2024 (ECR 2024), Abstracts.
- 2023
- Clinical application of the prostate cancer radiological estimation of change in sequential evaluation score for reporting magnetic resonance imaging in men on active surveillance for prostate cancer (2023) EUROPEAN UROLOGY OPEN SCIENCE. 56. p.39-46
- Clinical application of the PRECISE score for reporting magnetic resonance imaging in men on active surveillance for prostate cancer (2023) INSIGHTS INTO IMAGING. In Insights into Imaging 14(Supplement 4). p.247-247
- Clinical application of the PRECISE score for reporting magnetic resonance imaging in men on active surveillance for prostate cancer (2023) EUROPEAN UROLOGY. In European Urology 83(Supplement 1). p.S1376-S1377
- Clinical application of the PRECISE score for reporting magnetic resonance imaging in men on active surveillance for prostate cancer (2023) 10th Belgian Multidisciplinary meeting on Urological Cancers (BMUC 2023), Abstracts.
- The diagnostic accuracy of PSMA PET/CT versus MRI in patients with prostate cancer : a comparison of the PI-RADS, PRIMARY and miPSMA score (2023) 10th Belgian Multidisciplinary meeting on Urological Cancers (BMUC 2023), Abstracts.
- Success rate of in-bore MRI-guided prostate biopsy based on radical prostatectomy and/or follow-up (2023) European Congress of Radiology 2023 (ECR 2023), Abstracts.
- Is it safe to switch from a standard anterior to Retzius-sparing approach in robot-assisted radical prostatectomy? (2023) CURRENT ONCOLOGY. 30(3). p.3447-3460
- Global variation in magnetic resonance imaging quality of the prostate (2023) RADIOLOGY. 309(1).
- 2021
- Health-related quality of life in patients with advanced prostate cancer : a systematic review (2021) EUROPEAN UROLOGY FOCUS. 7(4). p.742-751
- How does PI-RADS v2.1 impact patient classification? A head-to-head comparison between PI-RADS v2.0 and v2.1 (2021) ACTA RADIOLOGICA. 62(6). p.839-847
- 2020
- External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection (2020) EUROPEAN UROLOGY. 78(2). p.138-142
- T-staging of prostate cancer : identification of useful signs to standardize detection of posterolateral extraprostatic extension on prostate MRI (2020) CLINICAL IMAGING. 59(1). p.1-7
- 2019
- A systematic review on the role of imaging in early recurrent prostate cancer (2019) EUROPEAN UROLOGY ONCOLOGY. 2(1). p.47-76
- Prostate mpMRI and MRI-targeted biopsy : state-of-the-art protocol + PI-RADS v2.1 (2019) JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY. 103(1).
- Multiparametric MRI of the prostate : from scientific triumph to daily practice (2019) JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY. 103(1).
- T-staging of prostate cancer : prevalence and predictive value of frequently used signs of extracapsular extension on prostate MRI (2019) ISMRM 27th Annual meeting, Abstracts.
- Imaging modalities in synchronous oligometastatic prostate cancer (2019) WORLD JOURNAL OF UROLOGY. 37(12). p.2573-2583
- Salvage lymph node dissection for nodal recurrent prostate cancer : a systematic review (2019) EUROPEAN UROLOGY. 76(4). p.493-504
- Aggressive variants of prostate cancer : are we ready to apply specific treatment right now? (2019) CANCER TREATMENT REVIEWS. 75. p.20-26
- Hereditary prostate cancer : primetime for genetic testing? (2019) CANCER TREATMENT REVIEWS. 81.
- Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? : a retrospective study in a high-volume academic center (2019) EUROPEAN JOURNAL OF RADIOLOGY. 114. p.92-98
- Positive pre-biopsy MRI : are systematic biopsies still useful in addition to targeted biopsies? (2019) WORLD JOURNAL OF UROLOGY. 37(2). p.243-251
- Nodal oligorecurrent prostate cancer : anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates (2019) EUROPEAN UROLOGY. 75(5). p.826-833
- 2018
- Improving the diagnosis of clinically significant prostate cancer with magnetic resonance imaging (2018) JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY. 102(1).
- T-staging of prostate cancer : prevalence and predictive value of frequently used signs of extracapsular extension on prostate MRI (2018) ECR Online 2018.
- Focal therapy in localised prostate cancer : real-world urological perspective explored in a cross-sectional European survey (2018) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 36(12). p.529.e11-529.e22
- Prostate magnetic resonance imaging provides limited incremental value over the Memorial Sloan Kettering Cancer Center preradical prostatectomy nomogram : editorial comment (2018) UROLOGY. 113. p.127-128
- MRI in prostate cancer diagnosis, surgical or radiation treatment, focal therapy, active surveillance and follow-up (2018) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 12(7). p.313-318
- Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial (2018) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 36(4). p.158.e13-158.e20
- Multidisciplinary approach to prostatitis (2018) ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA. 90(4). p.227-248
- 2017
- The T1 hemorrhage exclusion sign in the detection of prostate cancer at MRI (2017) JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY. 101(1).
- Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate (2017) EUROPEAN RADIOLOGY. 27(5). p.2095-2109
- Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA (2017) CLINICAL RADIOLOGY. 72(1). p.23-32
- Detection of clinically significant prostate cancer : short dual-pulse sequence versus standard multiparametric MR imaging : a multireader study (2017) RADIOLOGY. 284(3). p.725-736
- Whole pelvis radiotherapy for pathological node-positive prostate cancer (2017) STRAHLENTHERAPIE UND ONKOLOGIE. 193(6). p.444-451
- 2016
- Improving the diagnosis of clinically significant prostate cancer with magnetic resonance imaging (2016)
- What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging? (2016) EUROPEAN RADIOLOGY. 26(4). p.1098-1107
- Role of multiparametric magnetic resonance imaging in early detection of prostate cancer (2016) INSIGHTS INTO IMAGING. 7(2). p.205-214
- The multiparametric magnetic resonance imaging characteristics of the normal, benign and malignant conditions in the prostate (2016) INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 38(suppl. 1). p.S18-S18
- Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) version 1 and 2 in a cohort of 245 patients with histopathological reference and long-term follow-up (2016) JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY. 100(1).
- Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion : analysis of genito-urinary and rectal toxicity (2016) RADIOTHERAPY AND ONCOLOGY. 119(3). p.398-404
- Whole pelvis intensity-modulated arc therapy for lymph node metastasized prostate cancer: oncologic outcomes and prognostic factors (2016) EUROPEAN UROLOGY SUPPLEMENTS. 15(3). p.e680-e680
- Practice patterns compared with evidence-based strategies for the management of androgen deprivation therapy-induced side effects in prostate cancer patients : results of a European web-based survey (2016) EUROPEAN UROLOGY FOCUS. 2(5). p.514-521
- The outcome for patients with pathologic node-positive prostate cancer treated with intensity modulated radiation therapy and androgen deprivation therapy: a case-matched analysis of pN1 and pN0 patients (2016) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 96(2). p.323-332
- 2015
- Prostate magnetic resonance spectroscopic imaging at 1.5 Tesla with endorectal coil versus 3.0 Tesla without endorectal coil: comparison of spectral quality (2015) CLINICAL IMAGING. 39(4). p.636-641
- mpMRI-histopathologic correlation of normal, benign and malignant conditions of the prostate (2015) EUROPEAN UROLOGY SUPPLEMENTS. 14(7). p.226-226
- mpMRI-Histopathologic correlation of normal, benign and malignant conditions in the prostate (2015) Urogenital Radiology, 22nd European symposium, Abstracts.
- Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging?: a systematic review of the literature (2015) EUROPEAN UROLOGY. 68(6). p.1045-1053
- What kind of high-grade prostate cancers do we miss on multiparametric magentic resonance imaging? (2015) Electronic Presentation Online System.
- How bad is the outcome of node positive prostate cancer patients: a matched case analysis between N+ and N0 prostate cancer patients (2015) EUROPEAN UROLOGY SUPPLEMENTS. 14(7). p.174-175
- Prognostic effect of neuroendocrine differentiation in prostate cancer : a critical review (2015) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 33(6). p.265.e1-265.e7
- The oncologic role of local treatment in primary metastatic prostate cancer (2015) WORLD JOURNAL OF UROLOGY. 33(6). p.755-761
- What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series (2015) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 33(4). p.164.e1-164.e9
- Clinical perspectives from randomized phase 3 trials on prostate cancer : an analysis of the ClinicalTrials.gov database (2015) EUROPEAN UROLOGY FOCUS. 1(2). p.173-184
- Preferences for the management of androgen deprivation-induced osteoporosis and metabolic syndrome in prostate cancer patients: A European web-based survey (2015)
- Systematic ultrasound-guided saturation and template biopsy of the prostate : indications and advantages of extended sampling (2015) ARCHIVOS ESPANOLES DE UROLOGIA. 68(3). p.296-306
- Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome (2015) BIOMED RESEARCH INTERNATIONAL.
- Preferences in management of high-risk prostate cancer among urologists in Europe: results of a web-based survey (2015) BJU INTERNATIONAL. 115(4). p.571-579
- 2014
- Secondary infertility caused by a midline cyst of the prostate (2014) JBR-BTR. 97(5). p.317-317
- Salvage pelvic lymph node dissection in prostate cancer: surgical and oncological outcome (2014) EUROPEAN UROLOGY SUPPLEMENTS. 13(5). p.140-141
- What kind of high-grade prostate cancers do we miss with multiparametric magnetic resonance imaging? (2014) European Society of Urogenital Radiology, Fall meeting, Abstracts.
- Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications (2014) INTERNATIONAL JOURNAL OF UROLOGY. 21(11). p.1138-1143
- Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring? (2014) CLINICAL GENITOURINARY CANCER. 12(3). p.160-166
- 2013
- Imaging treated prostate cancer (2013) ABDOMINAL IMAGING. 38(6). p.1431-1446
- The role of functional magnetic resonance imaging techniques (2013) Prostate cancer : a comprehensive perspective. p.499-510
- Management of locally recurrent disease (2013) Prostate cancer : a comprehensive perspective. p.817-829
- MRI+MRSI reliably detects and excludes high-grade prostate cancer in patients (2013) European congress of Radiology, Abstracts.
- Metastasis-directed therapy for oligmetastic prostate recurrence (2013) Urological Cancers, 5th European multidisciplinary meeting, Abstracts.
- 2012
- Detection, localisation and exclusion of high grade prostate cancer with multiparametric MRI: correlation with radical prostatectomy histopathology (2012) Prostate Cancer, Global congress, Abstracts.
- Screening and early diagnosis of prostate cancer: an update (2012) ACTA CLINICA BELGICA. 67(4). p.270-275
- Prostate MRI at 3.0T versus endorectal 1.5T: comparison of spectral and overall image quality (2012) Urogenital Radiology, 19th European symposium, Abstracts.
- Population screening for prostate cancer: an overview of available studies and meta-analysis (2012) INTERNATIONAL JOURNAL OF UROLOGY. 19(2). p.100-108
- Comparison of qualitative and quantitative approach to prostate MR spectroscopy in peripheral zone cancer detection (2012) EUROPEAN JOURNAL OF RADIOLOGY. 81(3). p.411-416
- 2011
- Combined magnetic resonance imaging and spectroscopy in the exclusion of high grade prostate carcinoma in patients with elevated PSA (2011) Abdominal Radiology, Abstracts of the course.
- Comparison of qualitative and quantitative approach to prostate MR spectroscopy in peripheral zone cancer detection (2011) ECR 2011 : book of abstracts.
- Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients (2011) EUROPEAN JOURNAL OF RADIOLOGY. 77(2). p.340-345
- 2010
- Clinical and imaging tools in the early diagnosis of prostate cancer: a review (2010) JBR-BTR. 93(2). p.62-70
- Role of MRI in follow-up after focal therapy for prostate carcinoma (2010) AMERICAN JOURNAL OF ROENTGENOLOGY. 194(6). p.1427-1433
- MRI of the prostate (2010) UROBEL MAGAZINE. p.13-16
- Magnetic resonance imaging in diagnosis, staging and radiotherapy planning for prostate cancer (2010) ACTA CLINICA BELGICA. 65(6). p.371-376